Frans Wackers

Last updated
Frans Wackers
Frans Wackers.jpg
Born
Frans Jozef Thomas Wackers

1939
CitizenshipDutch
Education University of Amsterdam (Ph.D.), Amsterdam School of Medicine (M.D.)
Occupation(s) Cardiologist, Research Scientist
Known forVisualizing heart disease with radioisotope thallium-201 for heart imaging
Medical career
Institutions Yale University School of Medicine
Research Nuclear cardiology
Notable worksClinical cardiac imaging applications with radiotracers

Frans Jozef Thomas Wackers (born 1939) is a Dutch American clinical cardiologist and research scientist known for his contributions to nuclear cardiology. In 1974, he explored a new way of visualizing heart disease. He pioneered using the radioisotope thallium-201 for heart imaging, which started a new cardiology sub-specialty, later called Nuclear Cardiology. Wackers was the director of the Cardiovascular Nuclear Imaging and Stress Laboratories at Yale School of Medicine for 22 years. In 2008, he became a Professor Emeritus at Yale University. On January 1, 2013, Wackers fully retired from clinical and scientific responsibilities. [1]

Contents

Early life

Wackers was born on May 29, 1939, in Echt, Limburg, a rural town in the south of the Netherlands. His father, Thomas F. J. Wackers, from Maasniel, Limburg, was a urologist-surgeon in The Hague. His mother, Miep Koopman, from Amsterdam, passed away at age 44 when Frans was 16 years old. [2]

In Limburg, Wackers saw the beginning of World War II and five years of German Nazi occupation. In January 1945, Frans as a young boy, also experienced the fierce fighting and bloody battle between British and German troops during Operation Blackcock in the Roermond Triangle, in the middle of which the Germans evacuated Frans' family. [2]

Education and positions held

After the liberation of the Netherlands from the Nazi occupation, his family moved in September 1945 to Amsterdam. Wackers attended elementary school in Amsterdam, High School (Jesuit Aloysius College) in The Hague, and Medical School at the University of Amsterdam (UvA). [1]

While a medical school student, Wackers began research in 1963 as a student-research-assistant in the UvA Anatomical Pathology Laboratory under the mentorship of Professor Jan Hampe. Frans' research involved the investigation of the microanatomy of the female mammary gland.In 1966, Wackers continued his research during a 6-month scholarship at the cancer center, Institut Gustave Roussy, in Paris France. Wackers' description of a histological localized bionecrosis in breast tissue was later recognized as an early description of apoptosis. [3]

In 1970, Wackers earned his Ph.D. from the University of Amsterdam. He graduated with an M.D. from the Amsterdam School of Medicine in the same year. [4]

From 1972 to 1974, Wackers pursued his Internal Medicine Residency at the Wilhelmina Gasthuis University Hospital in Amsterdam and subsequently continued with a Cardiology Fellowship at the same institution from 1974 to 1977. [5]

His career in the United States began in 1977 with the recruitment as an Assistant Professor by the Section of Cardiovascular Medicine at Yale University School of Medicine, New Haven, CT. Later, he was appointed Associate Professor at the University of Vermont College of Medicine (1981–1984). He returned to Yale University School of Medicine and became a full Professor with tenure in Diagnostic Radiology and Medicine (Cardiology) in 1986. Wackers continued his clinical research and published more than 350 scientific publications in medical journals. [6]

The Evolution of Nuclear Cardiology

Wackers was a pioneer in exploring and advancing new clinical cardiac imaging applications with radiotracers, particularly thallium-201, for detecting coronary artery disease. In 1974, he was the first physician to administer the radioisotope thallium-201 to patients with acute heart disease. His 1976 publication with images of patients with acute heart attacks contributed to the widespread acceptance of clinical thallium -201 imaging. He strongly advocated digitizing and quantifying cardiac images and standardization of imaging protocols. [7]

Wackers was involved with the clinical introduction of new radiopharmaceuticals labeled with technetium-99m (sestamibi and tetrofosmin); the transitioning from planar imaging to three-dimensional imaging with Single Photon Emission Computerized Tomography (SPECT). In 1993, along with a core group of clinical investigators, he founded the American Society of Nuclear Cardiology (ASNC). He established the Certification Board of Nuclear Cardiology (CBNC) in 1996 and the Intersocietal Commission for Accreditation of Nuclear Laboratories (ICANL) in 1997. [8]

Affiliations

Wackers also co-chaired the 2003 and 2005 International Conference of Nuclear Cardiology in Florence and Lisbon.

Awards

Publications

He was on the Editorial Board of the Journal of the American College of Cardiology, the American Journal of Cardiology, and Journal of Nuclear Cardiology.

He has published more than 340 articles on nuclear cardiology and clinical cardiology. [1]

Selected articles

Books

Related Research Articles

<span class="mw-page-title-main">Single-photon emission computed tomography</span> Nuclear medicine tomographic imaging technique

Single-photon emission computed tomography is a nuclear medicine tomographic imaging technique using gamma rays. It is very similar to conventional nuclear medicine planar imaging using a gamma camera, but is able to provide true 3D information. This information is typically presented as cross-sectional slices through the patient, but can be freely reformatted or manipulated as required.

<span class="mw-page-title-main">Nuclear medicine</span> Medical specialty

Nuclear medicine or nucleology is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear imaging, in a sense, is "radiology done inside out" because it records radiation emitted from within the body rather than radiation that is transmitted through the body from external sources like X-ray generators. In addition, nuclear medicine scans differ from radiology, as the emphasis is not on imaging anatomy, but on the function. For such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.

<span class="mw-page-title-main">Cardiac stress test</span> Measures the hearts ability to respond to external stress in a controlled clinical environment

A cardiac stress test is a cardiological examination that evaluates the cardiovascular system's response to external stress within a controlled clinical setting. This stress response can be induced through physical exercise or intravenous pharmacological stimulation of heart rate.

<span class="mw-page-title-main">Coronary thrombosis</span> Medical condition

Coronary thrombosis is defined as the formation of a blood clot inside a blood vessel of the heart. This blood clot may then restrict blood flow within the heart, leading to heart tissue damage, or a myocardial infarction, also known as a heart attack.

Technetium (<sup>99m</sup>Tc) sestamibi Pharmaceutical drug

Technetium (99mTc) sestamibi (INN) is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six (sesta=6) methoxyisobutylisonitrile (MIBI) ligands. The anion is not defined. The generic drug became available late September 2008. A scan of a patient using MIBI is commonly known as a "MIBI scan".

<span class="mw-page-title-main">Scintigraphy</span> Diagnostic imaging test in nuclear medicine

Scintigraphy, also known as a gamma scan, is a diagnostic test in nuclear medicine, where radioisotopes attached to drugs that travel to a specific organ or tissue (radiopharmaceuticals) are taken internally and the emitted gamma radiation is captured by gamma cameras, which are external detectors that form two-dimensional images in a process similar to the capture of x-ray images. In contrast, SPECT and positron emission tomography (PET) form 3-dimensional images and are therefore classified as separate techniques from scintigraphy, although they also use gamma cameras to detect internal radiation. Scintigraphy is unlike a diagnostic X-ray where external radiation is passed through the body to form an image.

<span class="mw-page-title-main">Cardiac marker</span>

Cardiac markers are biomarkers measured to evaluate heart function. They can be useful in the early prediction or diagnosis of disease. Although they are often discussed in the context of myocardial infarction, other conditions can lead to an elevation in cardiac marker level.

<span class="mw-page-title-main">Radioisotope renography</span>

Radioisotope renography is a form of medical imaging of the kidneys that uses radiolabelling. A renogram, which may also be known as a MAG3 scan, allows a nuclear medicine physician or a radiologist to visualize the kidneys and learn more about how they are functioning. MAG3 is an acronym for mercapto acetyl tri glycine, a compound that is chelated with a radioactive element – technetium-99m.

Rubidium-82 chloride is a form of rubidium chloride containing a radioactive isotope of rubidium. It is marketed under the brand name Cardiogen-82 by Bracco Diagnostics for use in Myocardial perfusion imaging. It is rapidly taken up by heart muscle cells, and therefore can be used to identify regions of heart muscle that are receiving poor blood flow in a technique called PET perfusion imaging. The half-life of rubidium-82 is only 1.27 minutes; it is normally produced at the place of use by rubidium generators.

<span class="mw-page-title-main">Michel Ter-Pogossian</span> American medical physicist

Michel Matthew Ter-Pogossian was an American medical physicist. He was professor of radiology at the Washington University School of Medicine for over 30 years. A pioneer in nuclear medicine, he is best known for his research on the positron emission tomography (PET). He is considered one of its creators and often referred to as the "father of PET."

<span class="mw-page-title-main">Technetium-99m</span> Metastable nuclear isomer of technetium-99

Technetium-99m (99mTc) is a metastable nuclear isomer of technetium-99, symbolized as 99mTc, that is used in tens of millions of medical diagnostic procedures annually, making it the most commonly used medical radioisotope in the world.

<span class="mw-page-title-main">Myocardial perfusion imaging</span> Nuclear medicine imaging method

Myocardial perfusion imaging or scanning is a nuclear medicine procedure that illustrates the function of the heart muscle (myocardium).

Avijit Lahiri is a researcher in cardiology in the UK.

Perfusion is the passage of fluid through the lymphatic system or blood vessels to an organ or a tissue. The practice of perfusion scanning is the process by which this perfusion can be observed, recorded and quantified. The term perfusion scanning encompasses a wide range of medical imaging modalities.

<span class="mw-page-title-main">Valentín Fuster</span> Spanish cardiologist

Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat.

Rubidium-82 (82Rb) is a radioactive isotope of rubidium. 82Rb is widely used in myocardial perfusion imaging. This isotope undergoes rapid uptake by myocardiocytes, which makes it a valuable tool for identifying myocardial ischemia in Positron Emission Tomography (PET) imaging. 82Rb is used in the pharmaceutical industry and is marketed as Rubidium-82 chloride under the trade names RUBY-FILL and CardioGen-82.

A diagnosis of myocardial infarction is created by integrating the history of the presenting illness and physical examination with electrocardiogram findings and cardiac markers. A coronary angiogram allows visualization of narrowings or obstructions on the heart vessels, and therapeutic measures can follow immediately. At autopsy, a pathologist can diagnose a myocardial infarction based on anatomopathological findings.

Sgarbossa's criteria are a set of electrocardiographic findings generally used to identify myocardial infarction in the presence of a left bundle branch block (LBBB) or a ventricular paced rhythm.

Duke Treadmill Score is one of the tools for predicting the risk of ischemia or infarction in the heart muscle. The calculation is done based on the information obtained from an exercise test by this formula:

Organotechnetium chemistry is the science of describing the physical properties, synthesis, and reactions of organotechnetium compounds, which are organometallic compounds containing carbon-to-technetium chemical bonds. The most common organotechnetium compounds are coordination complexes used as radiopharmaceutical imaging agents.

References

  1. 1 2 3 4 "Frans Wackers, MD, PhD". Yale University . Retrieved 2024-02-28.
  2. 1 2 3 Frans J. Th. Wackers, M.D Archived 2006-09-03 at the Wayback Machine Citation for all education and positions held
  3. Beller, George A.; History Corner (2020). "Frans J Th Wackers, MD, PhD (Born 1939)". Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology. 27 (5): 1439–1442. doi:10.1007/s12350-020-02351-6. ISSN   1532-6551. PMID   32964399.
  4. "Frans J. Th. Wackers | Henry Koerner Center for Emeritus Faculty". emeritus.yale.edu. Retrieved 2024-02-28.
  5. Frans Wackers
  6. "A tribute to Barry L. Zaret, MD". www.healio.com. Retrieved 2024-02-28.
  7. Beller, George A.; the History Corner (2020-10-01). "Frans J Th Wackers, MD, PhD (Born 1939)". Journal of Nuclear Cardiology. 27 (5): 1439–1442. doi:10.1007/s12350-020-02351-6. ISSN   1532-6551.
  8. "Frans J Th Wackers | Radcliffe Cardiology". www.radcliffecardiology.com. Retrieved 2024-02-28.